Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma

MLA

Nan Ge, et al. “Neoadjuvant Chemoradiotherapy plus Surgery versus Surgery Alone for Clinical Node‐negative Esophageal Carcinoma.” Thoracic Cancer, vol. 11, Aug. 2020, pp. 2618–29. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....95e99c43061c2d2b5c99c8da734c02f8&authtype=sso&custid=ns315887.

APA

Nan Ge, Zhentao Yu, Lei Gong, Guo-Dong Shi, Yucheng Wei, Hui-Jiang Gao, & Bin Han. (2020). Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma. Thoracic Cancer, 11, 2618–2629.

Chicago

Nan Ge, Zhentao Yu, Lei Gong, Guo-Dong Shi, Yucheng Wei, Hui-Jiang Gao, and Bin Han. 2020. “Neoadjuvant Chemoradiotherapy plus Surgery versus Surgery Alone for Clinical Node‐negative Esophageal Carcinoma.” Thoracic Cancer 11 (August): 2618–29. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....95e99c43061c2d2b5c99c8da734c02f8&authtype=sso&custid=ns315887.